210 related articles for article (PubMed ID: 37248149)
1. Clinical and translational relevance of intratumor heterogeneity.
Goyette MA; Lipsyc-Sharf M; Polyak K
Trends Cancer; 2023 Sep; 9(9):726-737. PubMed ID: 37248149
[TBL] [Abstract][Full Text] [Related]
2. Multiregion sequencing reveals the intratumor heterogeneity of driver mutations in TP53-driven non-small cell lung cancer.
Zhang LL; Kan M; Zhang MM; Yu SS; Xie HJ; Gu ZH; Wang HN; Zhao SX; Zhou GB; Song HD; Zheng CX
Int J Cancer; 2017 Jan; 140(1):103-108. PubMed ID: 27646734
[TBL] [Abstract][Full Text] [Related]
3. Intratumor heterogeneity: evolution through space and time.
Swanton C
Cancer Res; 2012 Oct; 72(19):4875-82. PubMed ID: 23002210
[TBL] [Abstract][Full Text] [Related]
4. Intratumor heterogeneity: A new perspective on colorectal cancer research.
Zheng Z; Yu T; Zhao X; Gao X; Zhao Y; Liu G
Cancer Med; 2020 Oct; 9(20):7637-7645. PubMed ID: 32853464
[TBL] [Abstract][Full Text] [Related]
5. Cellular heterogeneity and molecular evolution in cancer.
Almendro V; Marusyk A; Polyak K
Annu Rev Pathol; 2013 Jan; 8():277-302. PubMed ID: 23092187
[TBL] [Abstract][Full Text] [Related]
6. Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.
Morris LG; Riaz N; Desrichard A; Şenbabaoğlu Y; Hakimi AA; Makarov V; Reis-Filho JS; Chan TA
Oncotarget; 2016 Mar; 7(9):10051-63. PubMed ID: 26840267
[TBL] [Abstract][Full Text] [Related]
7. Measuring intratumor heterogeneity by network entropy using RNA-seq data.
Park Y; Lim S; Nam JW; Kim S
Sci Rep; 2016 Nov; 6():37767. PubMed ID: 27883053
[TBL] [Abstract][Full Text] [Related]
8. Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.
Erramuzpe A; Cortés JM; López JI
Virchows Arch; 2018 Feb; 472(2):187-194. PubMed ID: 28842744
[TBL] [Abstract][Full Text] [Related]
9. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.
Dong LQ; Shi Y; Ma LJ; Yang LX; Wang XY; Zhang S; Wang ZC; Duan M; Zhang Z; Liu LZ; Zheng BH; Ding ZB; Ke AW; Gao DM; Yuan K; Zhou J; Fan J; Xi R; Gao Q
J Hepatol; 2018 Jul; 69(1):89-98. PubMed ID: 29551704
[TBL] [Abstract][Full Text] [Related]
10. A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.
Stanta G; Bonin S
Pathobiology; 2018; 85(1-2):7-17. PubMed ID: 28750401
[TBL] [Abstract][Full Text] [Related]
11. Phylogenetic Quantification of Intratumor Heterogeneity.
Watkins TBK; Schwarz RF
Cold Spring Harb Perspect Med; 2018 Apr; 8(4):. PubMed ID: 28710259
[TBL] [Abstract][Full Text] [Related]
12. DEPTH2: an mRNA-based algorithm to evaluate intratumor heterogeneity without reference to normal controls.
Song D; Wang X
J Transl Med; 2022 Apr; 20(1):150. PubMed ID: 35365157
[TBL] [Abstract][Full Text] [Related]
13. Turning the headlights on novel cancer biomarkers: Inspection of mechanics underlying intratumor heterogeneity.
McBride M; Rida PC; Aneja R
Mol Aspects Med; 2015 Nov; 45():3-13. PubMed ID: 26024970
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic heterogeneity in cancer.
Guo M; Peng Y; Gao A; Du C; Herman JG
Biomark Res; 2019; 7():23. PubMed ID: 31695915
[TBL] [Abstract][Full Text] [Related]
15. Defining multiple layers of intratumor heterogeneity based on variations of perturbations in multi-omics profiling.
Ai H; Song D; Wang X
Comput Biol Med; 2023 Jun; 159():106964. PubMed ID: 37099972
[TBL] [Abstract][Full Text] [Related]
16. DITHER: an algorithm for Defining IntraTumor Heterogeneity based on EntRopy.
Li L; Chen C; Wang X
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34096997
[TBL] [Abstract][Full Text] [Related]
17. Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma.
Hua X; Zhao W; Pesatori AC; Consonni D; Caporaso NE; Zhang T; Zhu B; Wang M; Jones K; Hicks B; Song L; Sampson J; Wedge DC; Shi J; Landi MT
Nat Commun; 2020 May; 11(1):2459. PubMed ID: 32424208
[TBL] [Abstract][Full Text] [Related]
18. Intratumor heterogeneity in evolutionary models of tumor progression.
Durrett R; Foo J; Leder K; Mayberry J; Michor F
Genetics; 2011 Jun; 188(2):461-77. PubMed ID: 21406679
[TBL] [Abstract][Full Text] [Related]
19. Pan-cancer analysis of intratumor heterogeneity associated with patient prognosis using multidimensional measures.
Kikutake C; Yoshihara M; Sato T; Saito D; Suyama M
Oncotarget; 2018 Dec; 9(102):37689-37699. PubMed ID: 30701024
[TBL] [Abstract][Full Text] [Related]
20. Leveraging Single-Cell Approaches in Cancer Precision Medicine.
Nath A; Bild AH
Trends Cancer; 2021 Apr; 7(4):359-372. PubMed ID: 33563578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
